Serological Survey on Monitoring the Positive Rate After Vaccination of Inactivated Polio Vaccine (NCT02643446) | Clinical Trial Compass
CompletedNot Applicable
Serological Survey on Monitoring the Positive Rate After Vaccination of Inactivated Polio Vaccine
China809 participantsStarted 2015-08
Plain-language summary
The Purpose of this study is to assess the seroconversion using inactivated poliovirus vaccine (IPV) and oral poliovirus vaccine (OPV) sequential schedule in pilot areas where IPV was phased introduced into national immunization program (NIP) in China.
Who can participate
Age range2 Months – 6 Months
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Healthy children who are regular residents in the pilot counties where the immune response is evaluated in pilot provinces.
* Receiving the polio vaccination at 2, 3 and 4 months old with an interval of 28-35 days between doses according to national immunization schedule. The first dose of vaccine was administered at 2 full months old and less than 3 full months old.
* No rotavirus vaccine was administered during the period of primary polio vaccinations, and no vaccines of category 2 (private market) were administered simultaneously with polio vaccine. If vaccines of category 2 other than rotavirus vaccine were administered, they should be administered with a space of at least 2 weeks with polio vaccination.
Exclusion Criteria:
* The first dose of polio vaccine was administered at more than 3 months old regardless of the reasons.
* Children didn't get proper type and doses of vaccine as the protocal required.
* Children with known immunodeficiency conditions.
* Immunosuppressive agents or blood products were used after birth.
* Vaccine contraindications.
What they're measuring
1
Seroconversion rate
Timeframe: One month after the specific dose of IPV or OPV
Trial details
NCT IDNCT02643446
SponsorCenters for Disease Control and Prevention, China